Trading Report: The DUPONT CAPITAL MANAGEMENT Corp Sold shares of Parexel International Corp. (PRXL)

The DUPONT CAPITAL MANAGEMENT Corp Sold shares of Parexel International Corp. (PRXL)

DUPONT CAPITAL MANAGEMENT Corp lowered its position in shares of Parexel International Corp. (NASDAQ:PRXL) by 21.9% during the second quarter, Holdings Channel reports. The institutional investor owned 61,941 shares of the company’s stock after selling 17,383 shares during the period. DUPONT CAPITAL MANAGEMENT Corp’s holdings in Parexel International Corp. were worth $3,895,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. LaSalle Street Capital Management LLC acquired a new position in shares of Parexel International Corp. during the second quarter worth $203,000. Magnetar Financial LLC acquired a new position in shares of Parexel International Corp. during the first quarter worth $215,000. LS Investment Advisors LLC increased its position in shares of Parexel International Corp. by 64.0% in the second quarter. LS Investment Advisors LLC now owns 3,501 shares of the company’s stock worth $220,000 after buying an additional 1,366 shares in the last quarter. M&T Bank Corp acquired a new position in shares of Parexel International Corp. during the first quarter worth $276,000. Finally, Eqis Capital Management Inc. increased its position in shares of Parexel International Corp. by 21.9% in the second quarter. Eqis Capital Management Inc. now owns 5,098 shares of the company’s stock worth $321,000 after buying an additional 916 shares in the last quarter. 95.46% of the stock is owned by institutional investors and hedge funds.

Shares of Parexel International Corp. (NASDAQ:PRXL) traded down 0.92% during midday trading on Friday, reaching $57.20. 980,904 shares of the company traded hands. The company has a 50 day moving average price of $67.61 and a 200 day moving average price of $64.98. The company has a market capitalization of $3054.82 billion, a PE ratio of 18.10 and a beta of 0.92. Parexel International Corp. has a 1-year low of $56.00 and a 1-year high of $71.13.

Parexel International Corp. (NASDAQ:PRXL) last released its quarterly earnings data on Wednesday, October 26th. The company reported $0.76 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.86 by $0.10. Parexel International Corp. had a return on equity of 30.68% and a net margin of 7.09%. The firm had revenue of $500.90 million for the quarter, compared to analyst estimates of $525.15 million. During the same quarter in the previous year, the business posted $0.70 earnings per share. Parexel International Corp.’s revenue for the quarter was down 2.2% on a year-over-year basis. On average, analysts expect that Parexel International Corp. will post $3.86 earnings per share for the current year.

PRXL has been the subject of a number of analyst reports. Citigroup Inc. raised their target price on shares of Parexel International Corp. from $74.00 to $80.00 and gave the company a “buy” rating in a research note on Friday, August 5th. Credit Suisse Group AG reaffirmed a “buy” rating on shares of Parexel International Corp. in a research note on Tuesday, September 27th. Evercore ISI reaffirmed a “buy” rating and set a $78.50 target price (up previously from $71.00) on shares of Parexel International Corp. in a research note on Friday, August 5th. Deutsche Bank AG decreased their target price on shares of Parexel International Corp. from $71.00 to $65.00 and set a “hold” rating for the company in a research note on Friday. Finally, Jefferies Group decreased their target price on shares of Parexel International Corp. from $72.50 to $67.00 and set a “hold” rating for the company in a research note on Thursday. One analyst has rated the stock with a sell rating, six have assigned a hold rating and four have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $68.50.

In other Parexel International Corp. news, insider Gadi Saarony sold 2,500 shares of Parexel International Corp. stock in a transaction dated Monday, August 15th. The shares were sold at an average price of $70.05, for a total transaction of $175,125.00. Following the completion of the sale, the insider now directly owns 9,417 shares in the company, valued at $659,660.85. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 2.70% of the company’s stock.

Parexel International Corp. Company Profile

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company, which provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products and services to the pharmaceutical, biotechnology and medical device industries across the world.

Related posts

Leave a Comment